• 1. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

Comprehensive Overview of 3-Amino-4,6-dichloropicolinonitrile (CAS No. 1073182-86-1): Properties, Applications, and Industry Insights

3-Amino-4,6-dichloropicolinonitrile (CAS No. 1073182-86-1) is a specialized heterocyclic compound with significant relevance in pharmaceutical and agrochemical research. This nitrile-functionalized picoline derivative features a unique combination of amino and chloro substituents, making it a versatile intermediate for synthesizing bioactive molecules. Its molecular structure, C₆H₃Cl₂N₃, offers excellent reactivity for cross-coupling reactions and nucleophilic substitutions, aligning with current trends in sustainable chemistry and green synthesis methodologies.

In recent years, the demand for high-purity 3-Amino-4,6-dichloropicolinonitrile has surged due to its role in developing crop protection agents and pharmaceutical scaffolds. Researchers prioritize this compound for its ability to introduce both electron-withdrawing (chloro) and electron-donating (amino) groups into complex molecular architectures. The compound’s thermal stability (decomposition point >200°C) and moderate solubility in polar aprotic solvents like DMF or DMSO further enhance its utility in high-throughput screening applications.

From an industrial perspective, CAS 1073182-86-1 exemplifies the growing focus on atom-efficient synthesis. Modern production methods emphasize catalytic amination techniques to reduce waste generation, addressing environmental concerns raised in ESG (Environmental, Social, and Governance) frameworks. Analytical characterization via HPLC-MS and NMR spectroscopy confirms its >98% purity, meeting stringent requirements for GMP-compliant manufacturing.

The compound’s mechanism of action in enzyme inhibition studies has attracted attention in drug discovery pipelines, particularly for kinase-targeted therapies. Its chloropyridine core serves as a privileged structure in designing small-molecule inhibitors, with published studies demonstrating efficacy against pathogenic targets. This aligns with the pharmaceutical industry’s shift toward precision medicine and personalized therapeutics.

Emerging applications include its use as a building block for fluorescent probes in bioimaging, leveraging the amino group’s derivatization potential. The 4,6-dichloro substitution pattern provides steric control in metal-catalyzed reactions, a feature exploited in materials science for creating functional polymers. Such multidisciplinary utility positions 3-Amino-4,6-dichloropicolinonitrile as a high-value chemical entity in the knowledge economy.

Quality control protocols for 1073182-86-1 typically involve ICH Q3D elemental impurity guidelines, reflecting heightened regulatory scrutiny. Storage recommendations (?20°C under inert atmosphere) ensure long-term stability, while structure-activity relationship (SAR) studies continue to reveal new pharmacophoric configurations enabled by this scaffold. The compound’s logP value (~2.1) suggests favorable membrane permeability, explaining its popularity in central nervous system (CNS) drug development.

Market analysts note increased patent filings incorporating 3-Amino-4,6-dichloropicolinonitrile derivatives, particularly in anticancer and antiviral applications. Its compatibility with continuous flow chemistry systems addresses manufacturing scalability challenges—a critical consideration for contract research organizations (CROs). Recent publications highlight its role in covalent inhibitor design through selective C–N bond formation strategies.

Environmental fate studies indicate moderate biodegradability for this compound, prompting development of benign-by-design analogs. The scientific community actively investigates its metabolic pathways using LC-TOF mass spectrometry, contributing to ADME/Tox prediction models. These advancements position CAS 1073182-86-1 as a benchmark for next-generation heterocyclic chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)